Schedio Scientific Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 14-01-2025
- Paid Up Capital ₹ 0.10 M
as on 14-01-2025
- Company Age 5 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.75 M
as on 14-01-2025
- Revenue 47.17%
(FY 2022)
- Profit -285.87%
(FY 2022)
- Ebitda -290.70%
(FY 2022)
- Net Worth -800.87%
(FY 2022)
- Total Assets 253.73%
(FY 2022)
About Schedio Scientific
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.75 M.
Aswathy, Dijin Jalaja, and Nirmalraj Remabai serve as directors at the Company.
- CIN/LLPIN
U36999KL2019PTC060623
- Company No.
060623
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Dec 2019
- Date of AGM
30 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Thiruvananthapuram, Kerala, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Schedio Scientific?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Aswathy | Director | 14-Oct-2023 | Current |
Dijin Jalaja | Director | 04-Dec-2019 | Current |
Nirmalraj Remabai | Director | 28-Dec-2023 | Current |
Financial Performance of Schedio Scientific.
Schedio Scientific Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 47.17% increase. The company also saw a substantial fall in profitability, with a 285.87% decrease in profit. The company's net worth observed a substantial decline by a decrease of 800.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Schedio Scientific?
Unlock access to Schedio Scientific's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
₹0.75 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.08 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
22 Mar 2023 | Others | ₹0.75 M | Open |
How Many Employees Work at Schedio Scientific?
Unlock and access historical data on people associated with Schedio Scientific, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Schedio Scientific, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Schedio Scientific's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.